Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 1
2002 2
2003 3
2004 3
2005 1
2006 2
2007 3
2008 2
2009 1
2010 5
2011 3
2012 1
2013 2
2014 5
2015 3
2016 3
2017 4
2018 3
2019 4
2020 12
2021 9
2022 11
2023 6

Text availability

Article attribute

Article type

Publication date

Search Results

74 results

Results by year

Filters applied: . Clear all
Page 1
Teriflunomide and Time to Clinical Multiple Sclerosis in Patients With Radiologically Isolated Syndrome: The TERIS Randomized Clinical Trial.
Lebrun-Frénay C, Siva A, Sormani MP, Landes-Chateau C, Mondot L, Bovis F, Vermersch P, Papeix C, Thouvenot E, Labauge P, Durand-Dubief F, Efendi H, Le Page E, Terzi M, Derache N, Bourre B, Hoepner R, Karabudak R, De Seze J, Ciron J, Clavelou P, Wiertlewski S, Turan OF, Yucear N, Cohen M, Azevedo C, Kantarci OH, Okuda DT, Pelletier D; TERIS Study Group. Lebrun-Frénay C, et al. Among authors: wiertlewski s. JAMA Neurol. 2023 Oct 1;80(10):1080-1088. doi: 10.1001/jamaneurol.2023.2815. JAMA Neurol. 2023. PMID: 37603328 Free article. Clinical Trial.
[Optic neuritis].
Meyniel C, Wiertlewski S. Meyniel C, et al. Among authors: wiertlewski s. Rev Med Interne. 2010 Jul;31(7):481-5. doi: 10.1016/j.revmed.2009.03.372. Rev Med Interne. 2010. PMID: 20434241 French.
Optic neuritis classification in 2021.
Ducloyer JB, Marignier R, Wiertlewski S, Lebranchu P. Ducloyer JB, et al. Among authors: wiertlewski s. Eur J Ophthalmol. 2021 Jul 3:11206721211028050. doi: 10.1177/11206721211028050. Online ahead of print. Eur J Ophthalmol. 2021. PMID: 34218696
COPP-MS: COrticosteroids during the Post-Partum in relapsing Multiple Sclerosis patients.
Leguy S, Lefort M, Lescot L, Michaud A, Vukusic S, Le Page E, Edan G, Kerbrat A, Lebrun-Frenay C, De Sèze J, Laplaud DA, Wiertlewski S, Leray E, Michel L. Leguy S, et al. Among authors: wiertlewski s. J Neurol. 2022 Oct;269(10):5571-5581. doi: 10.1007/s00415-022-11215-7. Epub 2022 Jun 23. J Neurol. 2022. PMID: 35737108 Free article.
Multiple Sclerosis CSF Is Enriched With Follicular T Cells Displaying a Th1/Eomes Signature.
Morille J, Mandon M, Rodriguez S, Roulois D, Leonard S, Garcia A, Wiertlewski S, Le Page E, Berthelot L, Nicot A, Mathé C, Lejeune F, Tarte K, Delaloy C, Amé P, Laplaud D, Michel L. Morille J, et al. Among authors: wiertlewski s. Neurol Neuroimmunol Neuroinflamm. 2022 Oct 20;9(6):e200033. doi: 10.1212/NXI.0000000000200033. Print 2022 Nov. Neurol Neuroimmunol Neuroinflamm. 2022. PMID: 36266053 Free PMC article.
Evaluation of efficacy and tolerability of first-line therapies in NMOSD.
Poupart J, Giovannelli J, Deschamps R, Audoin B, Ciron J, Maillart E, Papeix C, Collongues N, Bourre B, Cohen M, Wiertlewski S, Outteryck O, Laplaud D, Vukusic S, Marignier R, Zephir H; NOMADMUS study group. Poupart J, et al. Among authors: wiertlewski s. Neurology. 2020 Apr 14;94(15):e1645-e1656. doi: 10.1212/WNL.0000000000009245. Epub 2020 Mar 13. Neurology. 2020. PMID: 32170036
Predictive medicine in multiple sclerosis: A systematic review.
Havas J, Leray E, Rollot F, Casey R, Michel L, Lejeune F, Wiertlewski S, Laplaud D, Foucher Y. Havas J, et al. Among authors: wiertlewski s. Mult Scler Relat Disord. 2020 May;40:101928. doi: 10.1016/j.msard.2020.101928. Epub 2020 Jan 2. Mult Scler Relat Disord. 2020. PMID: 32004856
Disease reactivation after fingolimod cessation in Multiple Sclerosis patients with pregnancy desire: A retrospective study.
Callens A, Leblanc S, Le Page E, Edan G, Jourdain A, Coustans M, Wiertlewski S, Laplaud D, Videt D, Lallement F, Leray E, Michel L. Callens A, et al. Among authors: wiertlewski s. Mult Scler Relat Disord. 2022 Oct;66:104066. doi: 10.1016/j.msard.2022.104066. Epub 2022 Jul 22. Mult Scler Relat Disord. 2022. PMID: 35908450 Free article.
Comparative Effectiveness of Natalizumab Versus Anti-CD20 in Highly Active Relapsing-Remitting Multiple Sclerosis After Fingolimod Withdrawal.
Rollot F, Couturier J, Casey R, Wiertlewski S, Debouverie M, Pelletier J, De Sèze J, Labauge P, Ruet A, Thouvenot E, Ciron J, Berger E, Gout O, Clavelou P, Stankoff B, Casez O, Bourre B, Zephir H, Moreau T, Lebrun-Frenay C, Maillart E, Edan G, Neau JP, Montcuquet A, Cabre P, Camdessanché JP, Defer G, Nasr HB, Maurousset A, Hankiewicz K, Pottier C, Leray E, Vukusic S, Laplaud DA. Rollot F, et al. Among authors: wiertlewski s. Neurotherapeutics. 2022 Mar;19(2):476-490. doi: 10.1007/s13311-022-01202-1. Epub 2022 Feb 25. Neurotherapeutics. 2022. PMID: 35217934 Free PMC article.
74 results